PlumX Metrics
Embed PlumX Metrics

Expansion of DUB functionality generated by alternative isoforms - USP35, a case study

Journal of Cell Science, ISSN: 1477-9137, Vol: 131, Issue: 10
2018
  • 23
    Citations
  • 0
    Usage
  • 43
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Protein ubiquitylation is a dynamic post-translational modification that can be reversed by deubiquitylating enzymes (DUBs). It is unclear how the small number (~100) of DUBs present in mammalian cells regulate the thousands of different ubiquitylation events. Here, we analysed annotated transcripts of human DUBs and found ~300 ribosome-associated transcripts annotated as protein coding, which thus increases the total number of DUBs. By using USP35, a poorly studied DUB, as a case study, we provide evidence that alternative isoforms contribute to the functional expansion of DUBs. We show that there are two different USP35 isoforms that localise to different intracellular compartments and have distinct functions. Our results reveal that isoform 1 is an anti-apoptotic factor that inhibits staurosporine- and TNF-related apoptosis-inducing ligand (TRAIL; also known as TNFSF10)-induced apoptosis. In contrast, USP35 isoform 2 is an integral membrane protein of the endoplasmic reticulum (ER) that is also present at lipid droplets. Manipulations of isoform 2 levels cause rapid ER stress, likely through deregulation of lipid homeostasis, and lead to cell death. Our work highlights how alternative isoforms provide functional expansion of DUBs and sets directions for future research.

Bibliographic Details

Leznicki, Pawel; Natarajan, Jayaprakash; Bader, Gerd; Spevak, Walter; Schlattl, Andreas; Abdul Rehman, Syed Arif; Pathak, Deepika; Weidlich, Simone; Zoephel, Andreas; Bordone, Marie C.; Barbosa-Morais, Nuno L.; Boehmelt, Guido; Kulathu, Yogesh

The Company of Biologists

Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know